Manufacturer
KOTRA PHARMA (M) SDN. BHD.
Contents
Phentermine
Indication
Anorectic in short-term treatment of moderate to severe obesity.
Instruction
Adult: As phentermine HCl: 15-37.5 mg once daily in the morning; higher dose of 37.5 mg may be given in 2 divided doses. Individualise to achieve adequate response w/ lowest effective dose. As modified-release ion-exchange resin complex: 15-30 mg once daily in the morning.
Drug interaction
Primary pulmonary HTN or valvular heart disease may occur when phentermine is used concurrently w/ fenfluramine or dexfenfluramine. May decrease hypotensive effect of adrenergic neuron blocking drugs (e.g. guanethidine, clonidine, methyldopa). CNS stimulant effect may be increased by thyroid hormones.Potentially Fatal: Increased risk of hypertensive crisis w/ MAOI.
Malaysia
